IP Library Granted Patent US 11,970,724
Granted Patent B2
US 11,970,724 · App. 17/370,389 · Granted Apr 30, 2024

Serum-free cell culture medium

Inventors: Shadia Abike Oshodi (Jersey City, NJ); Amy S. Johnson (Briarcliff Manor, NY); Shawn M. Lawrence (Nyack, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C12P21/00C07K16/18C12N5/0031C12N5/0037C12N5/0043C12N5/005C12N5/0682C12N2500/22C12N2500/24C12N2500/32C12N2500/34C12N2500/46C12N2510/02C12N2511/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,970,724
App. No.
17/370,389
Granted
Apr 30, 2024
Kind
B2
Abstract

The specification describes an improved serum-free animal cell culture medium, which can used for the production of a protein of interest. Ornithine, or a combination of ornithine and putrescine can be added to serum-free media or chemically defined media to improve viable cell density, to reduce cell doubling time, and to increase the production of a protein of interest.

Claims (17)

1. A method for cultivating a CHO K1 cell expressing aflibercept, comprising:

(a) culturing the CHO K1 cell in a cell culture medium at a temperature of about 35° C. to 38° C. during a growth phase to form a cell culture, wherein said cell culture medium is serum-free and comprises plant hydrolysates, and is supplemented with 0.6±0.09 mM ornithine and 0.714±0.11 mM putrescine; and

(b) culturing the cell culture in the cell culture medium at a temperature of about 29° C. to 37° C. during a production phase;

wherein the cell culture has an increased viable cell culture density compared to an equivalent cell culture grown in a cell culture medium that is not supplemented with ornithine and putrescine.

2. The method of claim 1 , wherein step (b) comprises culturing the cell culture at a temperature of about 30° C. to 34° C. during the production phase.

3. The method of claim 1 , wherein the plant hydrolysates comprise less than or equal to 7.5 g/L soy hydrolysate.

4. The method of claim 1 , wherein the cell culture medium comprises:

(a) ≥40±6 mM of a mixture of amino acids or salts thereof;

(b) one or more fatty acids;

(c) a mixture of nucleosides; or

(d) one or more divalent cations.

5. The method of claim 4 , wherein:

(a) the mixture of amino acids or salts thereof comprises one or more of alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine or valine;

(b) the one or more fatty acids are selected from the group consisting of linoleic acid, linoleic acid, thioctic acid, oleic acid, palmitic acid, stearic acid, arachidic acid, arachidonic acid, lauric acid, behenic acid, decanoic acid, dodecanoic acid, hexanoic acid, lignoceric acid, myristic acid and octanoic acid;

(c) the mixture of nucleosides comprises one or more of adenosine, guanosine, cytidine, uridine, thymidine, or hypoxanthine; or

(d) the divalent cation is Ca 2+ , Mg 2+ , or both.

6. The method of claim 1 , wherein the method comprises a fed batch, continuous, semi-continuous or perfusion cell culture method.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2021
From: OSHODI, SHADIA ABIKE; JOHNSON, AMY S.; LAWRENCE, SHAWN M.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 057486/0191 →
Continuity (4)
Continuation 16742695 · Jan 14, 2020
Continuation 14211245 · Mar 14, 2014
Provisional Application 61790136 · Mar 15, 2013
Related Publication 20210332402A1 · Oct 28, 2021
Cited By (2)
US 12,668,774 US 12,686,847